{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T07:41:15Z","timestamp":1768722075746,"version":"3.49.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T00:00:00Z","timestamp":1651795200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T00:00:00Z","timestamp":1651795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Migraine headaches in children may cause attacks that require abortive treatment. This study evaluated the incidence and efficacy of medications used for relieving migraine headache attacks in the pediatric population in Israel. Children 6\u201318\u00a0years of age who were diagnosed in our pediatric neurology clinic as having migraine headaches were enrolled into the study. Children and their parents recorded the children response to abortive treatment during consecutive migraine attacks. Fifty children, with 116 migraine attacks, were included in the study (30 females; mean age 12; range 6\u201318). Forty-seven (94%) reported on abortive treatment on the first migraine attack, 43 (86%) on a second migraine attack and 26 (52%) on a third migraine attack. During the first recorded migraine attack, 41 children (87.5%) reported taking only one type of medication for each headache episode, mainly ibuprofen or acetaminophen; less than a quarter used dipyrone (metamizol). Overall the improvement rate after two hours was 65.4%\u2009\u00b1\u200927 for ibuprofen, 59.8\u2009\u00b1\u200935.3 for acetaminophen and 50.9\u2009\u00b1\u200927.4 for dipyrone without statistical difference. However, in the first recorded headache episode, males had a significantly better response to acetaminophen, compared to ibuprofen (95%\u2009\u00b1\u200928 vs 75\u2009\u00b1\u200920). In conclusion, Children with migraine in Israel mainly use a single medication for each headache episode. Ibuprofen is the most commonly used abortive treatment; however, acetaminophen was associated with a better response among some of our patients.<\/jats:p>","DOI":"10.1038\/s41598-022-11467-3","type":"journal-article","created":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T10:19:45Z","timestamp":1651832385000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Migraine abortive treatment in children and adolescents in Israel"],"prefix":"10.1038","volume":"12","author":[{"given":"Jacob","family":"Genizi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana","family":"Lahoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rony","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,6]]},"reference":[{"key":"11467_CR1","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4172\/2472-1913.100011","volume":"1","author":"J Genizi","year":"2016","unstructured":"Genizi, J., Srugo, I. & Kerem, N. C. Primary headache in children and adolescents: From pathophysiology to diagnosis and treatment. J. Headache Pain Manag. 1, 2 (2016).","journal-title":"J. Headache Pain Manag."},{"issue":"1","key":"11467_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0333102417738202","volume":"38","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2018","unstructured":"Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition. Cephalalgia 38(1), 1\u2013211 (2018).","journal-title":"Cephalalgia"},{"key":"11467_CR3","doi-asserted-by":"publisher","first-page":"537","DOI":"10.2147\/JPR.S88207","volume":"8","author":"CD Malone","year":"2015","unstructured":"Malone, C. D., Bhowmick, A. & Wachholtz, A. B. Migraine: Treatments, comorbidities, and quality of life, in the USA. J. Pain Res. 8, 537\u2013547 (2015).","journal-title":"J. Pain Res."},{"issue":"4","key":"11467_CR4","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/j.1526-4610.2010.01618.x","volume":"50","author":"TR Smith","year":"2010","unstructured":"Smith, T. R., Nicholson, R. A. & Banks, J. W. Migraine education improves quality of life in a primary care setting. Headache 50(4), 600\u2013612 (2010).","journal-title":"Headache"},{"key":"11467_CR5","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1542\/peds.112.1.e1","volume":"112","author":"S Powers","year":"2003","unstructured":"Powers, S., Patton, S., Hommel, K. & Hershey, A. Quality of life in childhood migraines: Clinical impact and comparison to other chronic illnesses. Pediatrics 112, e1\u2013e5 (2003).","journal-title":"Pediatrics"},{"issue":"4 Suppl 2","key":"11467_CR6","first-page":"2S","volume":"105","author":"AD Hershey","year":"2005","unstructured":"Hershey, A. D. & Winner, P. K. Pediatric migraine: Recognition and treatment. Am. Osteopath. Assoc. 105(4 Suppl 2), 2S-8S (2005).","journal-title":"Am. Osteopath. Assoc."},{"key":"11467_CR7","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1177\/0333102411433042","volume":"32","author":"M Lanteri-Minet","year":"2012","unstructured":"Lanteri-Minet, M., Mick, G. & Allaf, B. Early dosing and efficacy of triptans in acute migraine treatment: The TEMPO study. Cephalalgia 32, 226\u2013235 (2012).","journal-title":"Cephalalgia"},{"key":"11467_CR8","first-page":"66","volume":"5","author":"J Genizi","year":"2017","unstructured":"Genizi, J. et al. Paediatric primary headache: Pharmacological and non-pharmacological treatments. Eur. Med. J. Neurol. 5, 66\u201372 (2017).","journal-title":"Eur. Med. J. Neurol."},{"issue":"2","key":"11467_CR9","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.nurx.2006.01.002","volume":"3","author":"DW Lewis","year":"2006","unstructured":"Lewis, D. W. & Winner, P. The pharmacological treatment options for pediatric migraine: An evidence-based appraisal. NeuroRx 3(2), 181\u2013191 (2006).","journal-title":"NeuroRx"},{"key":"11467_CR10","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s00228-002-0465-2","volume":"5","author":"K Hedenmalm","year":"2002","unstructured":"Hedenmalm, K. & Spigset, O. Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole). Eur. J. Clin. Pharmacol. 5, 265\u2013274 (2002).","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"1","key":"11467_CR11","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1212\/WNL.48.1.103","volume":"48","author":"ML Hamalainen","year":"1997","unstructured":"Hamalainen, M. L., Hoppu, K., Valkeila, E. & Santavuori, P. Ibuprofen or acetaminophen for the acute treatment of migraine in children. Neurology 48(1), 103\u2013107 (1997).","journal-title":"Neurology"},{"issue":"8","key":"11467_CR12","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1046\/j.1526-4610.2002.02180.x","volume":"42","author":"DW Lewis","year":"2002","unstructured":"Lewis, D. W. et al. Children\u2019s ibuprofen suspension for the acute treatment of pediatric migraine. Headache 42(8), 780\u2013786 (2002).","journal-title":"Headache"},{"key":"11467_CR13","first-page":"CD004842","volume":"7","author":"AS Ramacciotti","year":"2014","unstructured":"Ramacciotti, A. S., Soares, B. G. & Atallah, A. N. Dipyrone for acute primary headaches. Cochrane Database Syst. Rev. 7, CD004842 (2014).","journal-title":"Cochrane Database Syst. Rev."},{"issue":"11","key":"11467_CR14","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1212\/WNL.0000000000008095","volume":"93","author":"M Oskoui","year":"2019","unstructured":"Oskoui, M. et al. Practice guideline update summary: Acute treatment of migraine in children and adolescents. Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology 93(11), 487\u2013499 (2019).","journal-title":"Neurology"},{"key":"11467_CR15","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1212\/01.wnl.0000265212.90735.64","volume":"69","author":"ME Bigal","year":"2007","unstructured":"Bigal, M. E. et al. Migraine in adolescents: Association with socioeconomic status and family history. Neurology 69, 16\u201325 (2007).","journal-title":"Neurology"},{"issue":"4","key":"11467_CR16","first-page":"CD005220","volume":"4","author":"L Richer","year":"2016","unstructured":"Richer, L. et al. Drugs for the acute treatment of migraine in children and adolescents. Cochrane Database Syst. Rev. 4(4), CD005220 (2016).","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"11467_CR17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1212\/WNL.48.1.103","volume":"48","author":"ML H\u00e4m\u00e4l\u00e4inen","year":"1997","unstructured":"H\u00e4m\u00e4l\u00e4inen, M. L., Hoppu, K., Valkeila, E. & Santavuori, P. Ibuprofen or acetaminophen for the acute treatment of migraine in children: A double-blind, randomized, placebo-controlled, crossover study. Neurology 48(1), 103\u2013107 (1997).","journal-title":"Neurology"},{"issue":"2","key":"11467_CR18","doi-asserted-by":"publisher","first-page":"e295","DOI":"10.1542\/peds.2004-2742","volume":"116","author":"L Damen","year":"2005","unstructured":"Damen, L. et al. Symptomatic treatment of migraine in children: A systematic review of medication trials. Pediatrics 116(2), e295-302 (2005).","journal-title":"Pediatrics"},{"issue":"3","key":"11467_CR19","first-page":"197","volume":"19","author":"FC Tulunay","year":"2004","unstructured":"Tulunay, F. C. et al. The efficacy and safety of dipyrone (Novalgin) tablets in the treatment of acute migraine attacks: A double-blind, cross-over, randomized, placebo-controlled, multi-center study. Funct. Neurol. 19(3), 197\u2013202 (2004).","journal-title":"Funct. Neurol."},{"issue":"12","key":"11467_CR20","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1111\/pan.13257","volume":"27","author":"TG de Leeuw","year":"2017","unstructured":"de Leeuw, T. G. et al. The use of dipyrone (metamizol) as an analgesic in children: What is the evidence? A review. Paediatr. Anaesth. 27(12), 1193\u20131201 (2017).","journal-title":"Paediatr. Anaesth."},{"key":"11467_CR21","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1046\/j.1526-4610.2002.02180.x","volume":"42","author":"DW Lewis","year":"2002","unstructured":"Lewis, D. W. et al. Children\u2019s ibuprofen suspension for the acute treatment of pediatric migraine. Headache 42, 780\u2013786 (2002).","journal-title":"Headache"},{"issue":"1","key":"11467_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1129-2377-14-21","volume":"14","author":"J Genizi","year":"2013","unstructured":"Genizi, J., Srugo, I. & Kerem, N. C. The cross-ethnic variations in the prevalence of headache and other somatic complaints among adolescents in Northern Israel. J. Headache Pain 14(1), 21 (2013).","journal-title":"J. Headache Pain"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-11467-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-11467-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-11467-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T02:46:01Z","timestamp":1669344361000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-11467-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,6]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["11467"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-11467-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,6]]},"assertion":[{"value":"30 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7418"}}